CPD and Education library

Study and gain CPD points through OT’s online CPD exams, and access archived CPD and CET articles, Practice team resources and Skills guides in our Education library

Find out more

Science and vision

News and features about the latest scientific developments and advances in optometry, ophthalmology and eye medicine

Find out more

Professional support

News and features about the latest developments relating to professional support from across optics. This includes updates from optical organisations such as the AOP and the GOC

Find out more

In practice

News and in-depth features about business management and career development in optics

Find out more


Explore the latest UK and global jobs in the optical sector for optometrists, dispensing opticians and more

Find out more

Tiny ‘ice cube tray’ could help restore sight

US researchers have developed a new scaffold that could help with the implantation of photoreceptors grown from stem cells

ice in a glass
Pixabay/Colin Behrens
Researchers at the University of Wisconsin-Madison have tackled the challenge of delivering photoreceptors to the retina with a tiny scaffold that resembles an ice cube tray.

The study, which is published in Science Advances, describes a micro-moulded patch designed to be implanted under a damaged or diseased retina.

University of Wisconsin-Madison
Photoreceptors grown from stem cells in an ice cube shaped scaffold.
Microscopy revealed that the completed scaffold was capable of holding more than 300,000 photoreceptors in approximately the area of the human macula.

Professor of electrical and computer engineering, Zhenqiang Ma, described the results as “exciting and significant.”

“Once we figured out the recipe, mass production became immediately possible, and commercialisation will be very easy. The fabrication methods can be used to create many other types of soft scaffolds for various biomedical applications,” he highlighted.

The research team is preparing the scaffold patch for surgical testing in large animals. If this step is successful, then the technology will be tested in humans.

David Gamm, director of the McPherson Eye Research Institute, shared his hope that early generation retinal patches will be safe and will restore some vision.

“Then we’ll be able to innovate and improve upon the technology and the outcomes over time,” he highlighted.